VILAZODONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vilazodone, and when can generic versions of Vilazodone launch?
Vilazodone is a drug marketed by Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa. and is included in five NDAs.
The generic ingredient in VILAZODONE is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vilazodone
A generic version of VILAZODONE was approved as vilazodone hydrochloride by TEVA PHARMS USA on September 30th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VILAZODONE?
- What are the global sales for VILAZODONE?
- What is Average Wholesale Price for VILAZODONE?
Summary for VILAZODONE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for VILAZODONE |
| What excipients (inactive ingredients) are in VILAZODONE? | VILAZODONE excipients list |
| DailyMed Link: | VILAZODONE at DailyMed |


